Position in UTHR
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$836,585
-$79,569 QoQ
Shares Held
1,544
-0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#486
of 870 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $6,951,552 across 44 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
143,876 | $4,874,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,544 | $836,585 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
3,008 | $506,968 | |
| 4 | ZTS |
Zoetis Inc.
|
2,994 | $215,148 | |
| 5 | LQDA |
Liquidia Corp
|
950 | $75,743 | |
| 6 | CTOR |
Citius Oncology, Inc.
|
107,424 | $69,825 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
447 | $49,590 | |
| 8 | VTRS |
Viatris Inc
|
2,398 | $38,080 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $836,585 | 1,544 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $916,154 | 1,545 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $846,840 | 1,738 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $651,452 | 1,554 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $621,825 | 2,164 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $536,081 | 1,739 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $301,678 | 855 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $375,909 | 1,049 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $139,206 | 437 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $92,806 | 404 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $117,861 | 536 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $93,736 | 415 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $117,880 | 534 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $50,167 | 224 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $96 | 562 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $153,894 | 735 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $111,929 | 475 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $7,355 | 41 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $8,211 | 38 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $7,014 | 38 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $6,817 | 38 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $6,356 | 38 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $5,768 | 38 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $3,838 | 38 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $3,267 | 27 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $853 | 9 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||